X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (371) 371
Conference Proceeding (18) 18
Publication (16) 16
Patent (13) 13
Book Chapter (9) 9
Newspaper Article (5) 5
Book Review (3) 3
Magazine Article (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Technical Report (2) 2
Reference (1) 1
Report (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (72) 72
male (41) 41
cardiac & cardiovascular systems (39) 39
energy & fuels (38) 38
female (38) 38
engineering, chemical (35) 35
middle aged (34) 34
analysis (31) 31
aged (29) 29
chemistry, physical (25) 25
chemistry (22) 22
clopidogrel (21) 21
treatment outcome (20) 20
biomass (19) 19
combustion (19) 19
acute coronary syndromes (18) 18
supercritical water (18) 18
thermodynamics (16) 16
percutaneous coronary intervention (15) 15
acute myocardial-infarction (14) 14
adult (14) 14
fuels (14) 14
gasification (14) 14
risk factors (14) 14
care and treatment (13) 13
hydrogen (13) 13
prospective studies (13) 13
acute coronary syndrome (12) 12
c-reactive protein (12) 12
carbon (12) 12
cardiac patients (12) 12
cardiology (12) 12
intervention (12) 12
materials science, multidisciplinary (12) 12
metallurgy (12) 12
myocardial infarction (12) 12
myocardial infarction - drug therapy (12) 12
platelet aggregation inhibitors - therapeutic use (12) 12
ticlopidine - analogs & derivatives (12) 12
adsorption (11) 11
biomarkers - blood (11) 11
lignocellulosic biomass (11) 11
nanoparticles (11) 11
oxidation (11) 11
randomized controlled trials as topic (11) 11
supercritical-water (11) 11
ticagrelor (11) 11
time factors (11) 11
adenosine - analogs & derivatives (10) 10
antiplatelet therapy (10) 10
aspirin (10) 10
coronary heart disease (10) 10
engineering (10) 10
environmental sciences (10) 10
management (10) 10
medicine, general & internal (10) 10
mortality (10) 10
physics, applied (10) 10
risk (10) 10
adolescent (9) 9
animals (9) 9
carbon dioxide (9) 9
catalysts (9) 9
cell biology (9) 9
chemistry, multidisciplinary (9) 9
heart attacks (9) 9
hydrogen-production (9) 9
peripheral vascular disease (9) 9
raman spectroscopy (9) 9
studies (9) 9
syngas (9) 9
vibrational spectra (9) 9
wasserstoff (9) 9
biochemistry (8) 8
crystallography (8) 8
dna replication (8) 8
glucose (8) 8
graphene (8) 8
heart attack (8) 8
hematology (8) 8
kinetics (8) 8
kohlenstoff (8) 8
medicine, research & experimental (8) 8
metallurgy & metallurgical engineering (8) 8
myocardial infarction - blood (8) 8
nucleic acid hybridization (8) 8
particles (8) 8
prasugrel (8) 8
pyrolysis (8) 8
stents (8) 8
supercritical water gasification (8) 8
temperature (8) 8
ticlopidine - therapeutic use (8) 8
acute coronary syndrome - drug therapy (7) 7
artery-disease (7) 7
biokraftstoff (7) 7
biomass energy (7) 7
biomasse (7) 7
cellulose (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
by Valgimigli, Marco and Haude, Michael and Aaroe, J and Aasa, M and Abdel-Salam, A.M and Alaarag, A.F and Accardi, R and Alcazar De La Torre, E and Alfonso Jimenez, V and Alhashimi, H.M.M and Aljeboury, A and Almeida De Sousa, J and Almusawi, A and Altaf, S and Altahmody, K.E.A and Andò, G and Andreou, A.Y and Angulo, J and Antonio, T and Aprigliano, G and Aquilina, M and Arampatzis, C.A and Araujo, J.J and Asher, E and Ates, I and Athanasias, D and Baglioni, P and Balducelli, M and Barbash, I.M and Barbosa, A.H.P and Basti, A and Bax, M and Beijk, M.A and Berroth, R and Berti, S and Berumen Dominguez, L.E and Bianco, M and Biasco, L and Bikicki, M and Bouferrouk, A and Bounartzidi, M and Bousoula, E and Brie, D and Brugaletta, S and Buchter, B and Burzotta, F and Butz, T and Buzzetti, F and Bychowiec, B and Cadeddu, M and Castiglioni, B and Cavalcante Silva, R and Cavalcanti, R.C and Cavazza, C and Chabane, H.K and Chaves, A.J and Chinchilla, H and Ciabatti, N and Coceani, M and Cóggiola, J and Conway, D.S.G and Cornelis, K and Coroleu, S.F and Cortese, B and Coskun, U and Costa, R.A and Coste, P and Coufal, Z and Cox, S and Cozma, A and Crean, P and Cristian, U and Cuculi, F and Cuenza, L and Dan Florin, F and Dana, A and Dangoisse, V and De Backer, O and De Cock, D and De Vita, M and Delgado, A and Dhamrait, S and Dievart, F and Dimitriadis, K and Dina, C and Doerner, O and Donahue, M and Dziewierz, A and Eftychiou, C and Elabbassi, W and Elesgerli, S and Elghetany, H and Elkahlout, A and Elrowiny, R and Elserafy, A.S and Emam, A and Emara, A and Emmanouil, P and Erglis, A and Esmaeil, S and ...
EuroIntervention, ISSN 1774-024X, 05/2015, Volume 11, Issue 1, pp. 68 - 74
Aims: Our aim was to report on a survey initiated by the EuropeanAssociation of Percutaneous Cardiovascular Interventions (EAPCI) concerning opinion on the... 
clopidogrel | CARDIAC & CARDIOVASCULAR SYSTEMS | acute coronary syndrome | drug-eluting stent | GUIDELINES | dual antiplatelet therapy (DAPT) | INTERVENTION | stable coronary artery disease
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 24, pp. 3006 - 3007
PPCI involving coronary artery aneurysms (CAAs) is challenging because of difficulties in “wiring” the distal part of the lesion, the presence of extensive... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Coronary Vessels - diagnostic imaging | Recurrence | Ultrasonography, Interventional - methods | Humans | Middle Aged | Coronary Aneurysm - complications | Male | ST Elevation Myocardial Infarction - diagnosis | Risk Adjustment - methods | Coronary Restenosis - diagnosis | Percutaneous Coronary Intervention - methods | Registries - statistics & numerical data | Female | ST Elevation Myocardial Infarction - etiology | Coronary Aneurysm - diagnostic imaging | Risk Factors | Kaplan-Meier Estimate | Tomography, Optical Coherence - methods | Coronary Restenosis - epidemiology | Outcome and Process Assessment (Health Care) | ST Elevation Myocardial Infarction - mortality | ST Elevation Myocardial Infarction - surgery | Aged | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Coronary heart disease | Care and treatment | Patient outcomes | Myocardial infarction | Surgical implants | Heart attacks | Disorders | Aneurysm | Aneurysms | Cardiovascular disease | Bleeding | Risk factors | Consortia | Confidence intervals | Wiring | Implants | Thromboembolism | Heart diseases | Stents | Anticoagulants | Medical imaging | Diabetes mellitus | Mortality | Coronary artery | Coronary artery disease | Patients | Thrombosis | Blood clots | Coronary vessels | Embolization | Death | Infarction | Acute coronary syndromes
Journal Article
Optics Express, ISSN 1094-4087, 08/2012, Volume 20, Issue 17, pp. 19463 - 19473
In this work we demonstrate comprehensive studies on graphene oxide (GO) and reduced graphene oxide (rGO) based saturable absorbers (SA) for mode-locking of... 
ULTRAFAST LASER | CARBON | REDUCTION | PHOTONICS | GRAPHITE OXIDE | GENERATION | OPTICS | ATOMIC-LAYER GRAPHENE | FEMTOSECOND LASER | Absorption | Lasers, Solid-State | Oxidation-Reduction | Light | Oxides - chemistry | Fiber Optic Technology - instrumentation | Graphite - chemistry | Equipment Design | Equipment Failure Analysis
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 04/2012, Volume 10, Issue 4, pp. 529 - 542
Background: Prognostic values of genotyping and phenotyping for assessment of clopidogrel responsiveness have been shown in independent studies.Objectives: To... 
clopidogrel | major bleeding | stent thrombosis | MEA | specificity | polymorphism | sensitivity | CYP2C19 | platelets | Sensitivity | Specificity | Clopidogrel | Stent thrombosis | Platelets | Major bleeding | Polymorphism | CYP2C19 GENOTYPE | OF-FUNCTION POLYMORPHISM | PLATELET-FUNCTION | BLEEDING EVENTS | TREATED PATIENTS | PERCUTANEOUS CORONARY INTERVENTION | GENETIC-VARIABILITY | 2C19-ASTERISK-17 ALLELIC VARIANT | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | MULTIPLE ELECTRODE AGGREGOMETRY | Predictive Value of Tests | Prospective Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Coronary Artery Disease - enzymology | Coronary Artery Disease - blood | Angioplasty, Balloon, Coronary - adverse effects | Austria | Phosphoproteins - blood | Angioplasty, Balloon, Coronary - mortality | Time Factors | Ticlopidine - adverse effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Platelet Aggregation Inhibitors - adverse effects | Risk Assessment | Gene Frequency | Risk Factors | Thrombosis - enzymology | Genotype | Logistic Models | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Phenotype | Coronary Artery Disease - therapy | Blood Platelets - metabolism | Coronary Artery Disease - genetics | Thrombosis - genetics | Hemorrhage - chemically induced | Multivariate Analysis | Phosphorylation | Ticlopidine - therapeutic use | Microfilament Proteins - blood | Cardiovascular Diseases - enzymology | Cardiovascular Diseases - genetics | Sensitivity and Specificity | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Thrombosis - blood | Thrombosis - prevention & control | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Cell Adhesion Molecules - blood | Pharmacogenetics | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - mortality | Chi-Square Distribution | Aryl Hydrocarbon Hydroxylases - metabolism | Cytochrome P-450 CYP2C19 | Aged | Transluminal angioplasty | Medical colleges | Analysis | Vasodilators | Cardiac patients | Cytochrome P-450 | Accountants | Diabetes | Cardiology | Thrombosis | Coronary heart disease | Blood clot
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e102701
Journal Article
Journal Article
Journal of Organometallic Chemistry, ISSN 0022-328X, 11/2005, Volume 690, Issue 21-22, p. 4719
High-pressure vibrational spectroscopic measurements on two heterobimetallic organometallic complexes are reported that may afford a new and useful way in... 
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2011, Volume 9, Issue 10, pp. 1902 - 1915
Journal Article
Journal Article